Arnaud Marcel Pierre Piettre

Title: Arnaud Marcel Pierre Piettre: Innovator in Pharmaceutical Chemistry

Introduction

Arnaud Marcel Pierre Piettre is a notable inventor based in Sierentz, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit the interaction between MDM2 and p53. His work is crucial in the ongoing fight against cancer, as the p53 protein plays a vital role in regulating the cell cycle and preventing tumor formation.

Latest Patents

Piettre holds a patent for "Inhibitors of the interaction between MDM2 and p53." This invention provides compounds of formula (I) that serve as inhibitors of the p53-MDM2 interaction. The patent outlines the use of these compounds in pharmaceutical compositions, detailing the specific meanings of various components such as n, s, t, R, X, Y, Q, Z, G, E, and D.

Career Highlights

Arnaud Piettre is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions that address critical health challenges. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Piettre has collaborated with esteemed colleagues, including Pierre-Henri Storck and Bruno Schoentjes. These collaborations have fostered an environment of innovation and have contributed to the advancement of research in pharmaceutical chemistry.

Conclusion

Arnaud Marcel Pierre Piettre is a distinguished inventor whose work in developing inhibitors of the p53-MDM2 interaction has significant implications for cancer treatment. His contributions to Janssen Pharmaceutica NV and collaborations with other experts highlight his commitment to advancing pharmaceutical science.